NCT05446532已完成不适用
Characteristics of Hepatitis B HBsAg & HBsAc Carriers Simultaneously
Corporacion Parc Tauli1 个研究点 分布在 1 个国家目标入组 120 人开始时间: 2022年6月15日最近更新:
适应症
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 发起方
- 入组人数
- 120
- 试验地点
- 1
- 主要终点
- prevalence concomitant HBsAg and HBsAc markers
研究概览
简要总结
HBV infection is a dynamic process with complex interactions between virus replication and the host's immune response. The appearance of anti-HBs after HBV infection generally indicates recovery and immunity to HBV1 infection. However, there are several published studies that describe the coexistence of the marker of chronic infection (HBsAg +) and the marker of functional cure (HBsAc +). There are contradictory studies on whether the coexistence of HBsAg/HBsAc implies a different clinical course.
研究设计
- 研究类型
- Observational
- 观察模型
- Cohort
- 时间视角
- Retrospective
入排标准
- 年龄范围
- 18 Years 至 90 Years（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •all those patients who have been seen in outpatient hepatology consultations and who present positive HBsAg and HBsAc serology simultaneously.
排除标准
- •Hepatitis C or HIV Co-infection
结局指标
主要结局
prevalence concomitant HBsAg and HBsAc markers
时间窗: 10 years
To describe the prevalence of concomitant HBsAg and HBsAc markers in our area
次要结局
- differences between immunocompetent patients with respect to immunocompromised ones.(10 years)
研究者
Mireia Miquel-Planas
Principal Investigator
Corporacion Parc Tauli
研究点 (1)
Loading locations...
相似试验
Unknown
不适用
Sustained Viral Response in Patients Achieved HBsAg Level≤100 IU/ml After Completed Interferon TreatmentChronic Hepatitis BNCT02348502Beijing Ditan Hospital160
Unknown
不适用
Sustained HBsAg and Viral Response in Patients Achieved HBsAg Loss by Interferon TreatmentChronic Hepatitis BNCT02336399Beijing Ditan Hospital420
已完成
不适用
A Comprehensive HBsAg-positive Patients Centered Screening StrategyHepatitis B and Hepatitis C (Disorder)NCT03794791Hong Ren10,000
Unknown
不适用
Cohort of Hepatitis B Research of AmsterdamHepatitis BNCT01462981Public Health Service of Amsterdam172
Unknown
不适用
Sustained Viral Response in Chronic Hepatitis B Patients Who Achieved HBeAg Seroncongversion After Interferon TherapyChronic Hepatitis BNCT02412592Beijing Ditan Hospital260